PMID: 6403342Apr 1, 1983Paper

Progabide: a controlled trial in partial epilepsy

Epilepsia
M DamH R Angelo

Abstract

Progabide (SL 76002) was studied in a randomized double-blind crossover trial using 20 outpatients suffering from partial complex seizures. Progabide was added to the concomitant antiepileptic treatment in a fixed dosage schedule. The design included an open therapy control unit. No significant difference was established between the number of partial seizures during treatment with progabide and placebo. A trend was observed for lower seizure frequency of secondary generalized seizures during treatment with progabide. Only mild and transient side effects were observed. There was no difference between the side effects of progabide and placebo.

References

May 26, 1972·Brain Research·N M Van GelderT Rasmussen
Jun 1, 1969·Journal of Neurochemistry·Y GodinP Mandel
Jul 1, 1981·Neurology·T L Perry, S Hansen
Oct 1, 1982·Epilepsia·L GramH Flachs
Jul 1, 1982·British Journal of Clinical Pharmacology·E J Boyd, K G Wormsley

❮ Previous
Next ❯

Citations

Mar 1, 1988·Digestive Diseases and Sciences·S J MunozW C Maddrey
Jan 26, 1985·Lancet
Jan 1, 1987·Epilepsia·G BianchettiP L Morselli
Nov 1, 1988·Epilepsia·N M GravesI E Leppik
Jan 1, 1993·Epilepsia·L Gram, D Schmidt
Jan 1, 1995·Epilepsia·L Gram
Jan 1, 1992·Acta Neurologica Scandinavica. Supplementum·A Richens
Feb 1, 1983·Acta Neurologica Scandinavica·H R PetersenM Dam
Mar 5, 2009·Journal of Child Neurology·Cynthia SharpeDoris A Trauner
Jan 1, 1985·Journal of Neurology·E NiedermeyerR S Fisher

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.